Cambridge Brain Mets Trial 1
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Breast Cancer|Brain Cancer|Advanced Breast Cancer|Advanced Lung Cancer
Interventions: DRUG: Afatinib|RADIATION: 2 Gy targeted radiotherapy|RADIATION: 4 Gy targeted radiotherapy
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Collaborators: Boehringer Ingelheim|Cancer Research UK|University of Cambridge|The Brain Tumour Charity